Latest Breaking News On - Credit suisse equity forum switzerland - Page 1 : vimarsana.com
Cosmo Pharmaceuticals N.V. / Key word(s): Regulatory ApprovalCosmo announces FDA grants orphan-drug designation ofrifamycin for treatment of pouchitis 20.10.2022 / 06:00 GMT/BSTDublin, Ireland – 20 October 2022. Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) announces that the FDA has granted the orpha.
Cosmo Pharmaceuticals N.V. / Key word(s): MiscellaneousGI Genius™ named to FORTUNE 2022 “Change the World” list 12.10.2022 / 06:00 GMT/BSTDublin, Ireland – 12 October 2022: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) announced today that Medtronic, its global partner for GI Genius™, published a medi.
Medacta Group SA / Key word(s): Half Year Results Medacta Group SA reports strong revenue growth of 19.0% and adjusted EBITDA margin of 27.5% in the first semester 2022 09-Sep-2022 / 07:00 CET/CEST Release
Medacta Group SA / Key word(s): Half Year Results09-Sep-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement. Press Release – Ad-hoc announcement pursuant to Art. 53 LR Medact.